|
1
|
Puccetti E and Ruthardt M: Acute
promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
Leukemia. 18:1169–1175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang K, Wang P, Shi J, Zhu X, He M, Jia X,
Yang X, Qiu F, Jin W, Qian M, et al: PML/RARalpha targets promoter
regions containing PU.1 consensus and RARE half sites in acute
promyelocytic leukemia. Cancer Cell. 17:186–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grisolano JL, Wesselschmidt RL, Pelicci PG
and Ley TJ: Altered myeloid development and acute leukemia in
transgenic mice expressing PML-RAR alpha under control of cathepsin
G regulatory sequences. Blood. 89:376–387. 1997.PubMed/NCBI
|
|
4
|
He LZ, Tribioli C, Rivi R, Peruzzi D,
Pelicci PG, Soares V, Cattoretti G and Pandolfi PP: Acute leukemia
with promyelocytic features in PML/RARalpha transgenic mice. Proc
Natl Acad Sci USA. 94:5302–5307. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Westervelt P, Lane AA, Pollock JL,
Oldfather K, Holt MS, Zimonjic DB, Popescu NC, DiPersio JF and Ley
TJ: High-penetrance mouse model of acute promyelocytic leukemia
with very low levels of PML-RARalpha expression. Blood.
102:1857–1865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Early E, Moore MA, Kakizuka A,
Nason-Burchenal K, Martin P, Evans RM and Dmitrovsky E: Transgenic
expression of PML/RARalpha impairs myelopoiesis. Proc Natl Acad Sci
USA. 93:7900–7904. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lane AA and Ley TJ: Neutrophil elastase
cleaves PML-RARalpha and is important for the development of acute
promyelocytic leukemia in mice. Cell. 115:305–318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lane AA and Ley TJ: Neutrophil elastase is
important for PML-retinoic acid receptor alpha activities in early
myeloid cells. Mol Cell Biol. 25:23–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao YM, Zhong L, Zhang X, Hu XX and Liu
BZ: PML(NLS−) inhibits cell apoptosis and promotes
proliferation in HL-60 cells. Int J Med Sci. 10:498–507. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu XX, Zhong L, Zhang X, Gao YM and Liu
BZ: NLS-RARα promotes proliferation and inhibits differentiation in
HL-60 cells. Int J Med Sci. 11:247–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sardiello M, Cairo S, Fontanella B,
Ballabio A and Meroni G: Genomic analysis of the TRIM family
reveals two groups of genes with distinct evolutionary properties.
BMC Evol Biol. 8:2252008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Salomoni P, Ferguson BJ, Wyllie AH and
Rich T: New insights into the role of PML in tumour suppression.
Cell Res. 18:622–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geng Y, Monajembashi S, Shao A, Cui D, He
W, Chen Z, Hemmerich P and Tang J: Contribution of the C-terminal
regions of promyelocytic leukemia protein (PML) isoforms II and V
to PML nuclear body formation. J Biol Chem. 287:30729–30742. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan D and Kao HY: The function,
regulation and therapeutic implications of the tumor suppressor
protein, PML. Cell Biosci. 5:602015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding W, Tong Y, Zhang X, Pan M and Chen S:
Study of arsenic sulfide in solid tumor cells reveals regulation of
nuclear factors of activated T-cells by PML and p53. Sci Rep.
6:197932016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang
Z, Miao Y, Zhu Y, Shi Y, Zhu J, et al: Stabilization of PML nuclear
localization by conjugation and oligomerization of SUMO-3.
Oncogene. 24:5401–5413. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rabellino A, Carter B, Konstantinidou G,
Wu SY, Rimessi A, Byers LA, Heymach JV, Girard L, Chiang CM,
Teruya-Feldstein J, et al: The SUMO E3-ligase PIAS1 regulates the
tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer
Res. 72:2275–2284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weisshaar SR, Keusekotten K, Krause A,
Horst C, Springer HM, Göttsche K, Dohmen RJ and Praefcke GJ:
Arsenic trioxide stimulates SUMO-2/3 modification leading to
RNF4-dependent proteolytic targeting of PML. FEBS Lett.
582:3174–3178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin G, Gao Y and Lin HK: Cytoplasmic PML:
From molecular regulation to biological functions. J Cell Biochem.
115:812–818. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lange A, Mills RE, Lange CJ, Stewart M,
Devine SE and Corbett AH: Classical nuclear localization signals:
Definition, function, and interaction with importin alpha. J Biol
Chem. 282:5101–5105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao C, Zhong L, Shan Z, Xu T, Gan L, Song
H, Yang R, Li L and Liu B: NLS-RARα inhibits the effects of
all-trans retinoic acid on NB4 cells by interacting with P38α MAPK.
Int J Med Sci. 13:611–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fanelli M, Minucci S, Gelmetti V, Nervi C,
Gambacorti-Passerini C and Pelicci PG: Constitutive degradation of
PML/RARalpha through the proteasome pathway mediates retinoic acid
resistance. Blood. 93:1477–1481. 1999.PubMed/NCBI
|
|
23
|
Jing Y, Xia L, Lu M and Waxman S: The
cleavage product deltaPML-RARalpha contributes to all-trans
retinoic acid-mediated differentiation in acute promyelocytic
leukemia cells. Oncogene. 22:4083–4091. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Le XF, Yang P and Chang KS: Analysis of
the growth and transformation suppressor domains of promyelocytic
leukemia gene, PML. J Biol Chem. 271:130–135. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gallagher R, Collins S, Trujillo J,
McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti
F, et al: Characterization of the continuous, differentiating
myeloid cell line (HL-60) from a patient with acute promyelocytic
leukemia. Blood. 54:713–733. 1979.PubMed/NCBI
|
|
26
|
Taube F, Stölzel F, Thiede C, Ehninger G,
Laniado M and Schaich M: Increased incidence of central nervous
system hemorrhages in patients with secondary acute promyelocytic
leukemia after treatment of multiple sclerosis with mitoxantrone?
Haematologica. 96:e312011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dekking EH, van der Velden VH, Varro R,
Wai H, Böttcher S, Kneba M, Sonneveld E, Koning A, Boeckx N, Van
Poecke N, et al: EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708):
Flow cytometric immunobead assay for fast and easy detection of
PML-RARA fusion proteins for the diagnosis of acute promyelocytic
leukemia. Leukemia. 26:1976–1985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dolz S, Barragán E, Fuster Ó, Llop M,
Cervera J, Such E, De Juan I, Palanca S, Murria R, Bolufer P, et
al: Novel real-time polymerase chain reaction assay for
simultaneous detection of recurrent fusion genes in acute myeloid
leukemia. J Mol Diagn. 15:678–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sueki A, Matsuda K, Taira C, Yamaguchi A,
Koeda H, Takagi F, Kobayashi Y, Sugano M and Honda T: Rapid
detection of PML-RARA fusion gene by novel high-speed
droplet-reverse transcriptase-polymerase chain reaction:
Possibility for molecular diagnosis without lagging behind the
morphological analyses. Clin Chim Acta. 415:276–278. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gomis F, Sanz J, Sempere A, Plumé G,
Senent ML, Pérez ML, Cervera J, Moscardó F, Bolufer P, Barragán E,
et al: Immunofluorescent analysis with the anti-PML monoclonal
antibody PG-M3 for rapid and accurate genetic diagnosis of acute
promyelocytic leukemia. Ann Hematol. 83:687–690. 2004. View Article : Google Scholar : PubMed/NCBI
|
